Global Markets
S&P 500 β€” US Large Cap Index
NASDAQ 100 β€” Tech Growth Index
Dow Jones β€” Industrial Average
FTSE 100 β€” UK Blue Chips
Euro Stoxx 50 β€” Eurozone Leaders
DAX 40 β€” German Equities
CAC 40 β€” French Market Index
Nikkei 225 β€” Japan Benchmark
Hang Seng β€” Hong Kong Index
Shanghai Composite β€” China Mainland
ASX 200 β€” Australian Market
TSX Composite β€” Canada Index
Nifty 50 β€” India Large Cap
STI Index β€” Singapore Market
KOSPI β€” South Korea Index
Bovespa β€” Brazil Equities
JSE Top 40 β€” South Africa Index
IPC Index β€” Mexico Market
S&P 500 β€” US Large Cap Index
NASDAQ 100 β€” Tech Growth Index
Dow Jones β€” Industrial Average
FTSE 100 β€” UK Blue Chips
Euro Stoxx 50 β€” Eurozone Leaders
DAX 40 β€” German Equities
CAC 40 β€” French Market Index
Nikkei 225 β€” Japan Benchmark
Hang Seng β€” Hong Kong Index
Shanghai Composite β€” China Mainland
ASX 200 β€” Australian Market
TSX Composite β€” Canada Index
Nifty 50 β€” India Large Cap
STI Index β€” Singapore Market
KOSPI β€” South Korea Index
Bovespa β€” Brazil Equities
JSE Top 40 β€” South Africa Index
IPC Index β€” Mexico Market
AED β€’ EUR β€’ GBP β€’ USD IBANs   |   CROSS BORDER FX   |   LOCAL CURRENCIES   |   GLOBAL COVERAGE
AIMarketsStocks

What’s Next for the AI Play?

Despite momentary optimism, driven by Micron’s strong quarterly results, the majority of semiconductor companies and nearly all hyperscalers closed the week in decline.

🌏 Asia We begin the new week with a sell-off in SK Hynix (-4.4%) and Samsung (-5.7%) shares; these companies account for approximately half of the KOSPI index’s capitalisation (-0.9%). Japan’s NIKKEI 225 (-1%) is also in the red, dragged down by poor performance from giant Kioxia (-9.4%), the largest company on the Japanese stock exchange, a manufacturer of flash memory and solid-state drives. Conversely, China’s Hang Seng (+2.6%) is in positive territory, supported by healthcare stocks benefiting from capital rotation. Gains were recorded by:

  • CSPC Pharmaceutical Group (+10%) – producer of innovative drugs (e.g., for cardiovascular or oncological diseases) and generics.
  • Innovent Biologics (+7.9%) – producer of advanced biological drugs, primarily modern anti-cancer and immunological therapies.
  • JD Health International (+6.9%) – China’s largest online pharmaceutical platform, connecting an e-pharmacy with telemedicine services and medical consultations.
  • Sino Biopharmaceutical (+6.8%) – a large, diversified medical conglomerate covering the full supply chain, from advanced R&D to drug distribution.

🌍 Geopolitics Weekend headlines remained dominated by issues surrounding the US-Iran conflict. On Sunday, President Trump accused Iran of violating the framework agreement, striking Iranian missile depots, drones, and radar points around the Strait of Hormuz. Tehran fired missiles and drones at the Ali Al Salem base in Kuwait and the Fifth Fleet base in Bahrain, while threatening to halt negotiations entirely. However, both sides are scheduled to return to negotiations on Tuesday, supporting a modest improvement in sentiment and a 0.7% rise in S&P 500 futures.

πŸ›’οΈ Commodities Crude oil prices remain at their lowest level since the outbreak of the war.

  • Brent crude oil is currently priced at approximately $72 per barrel.
  • WTI is slightly below $70.

Gas prices are also trending downwards:

  • NATGAS is hovering around $3.29 per MMBtu.
  • TTF MWh is priced at just over $41.

Precious metal prices remain at levels close to their recent lows.

  • The price of a troy ounce of gold is currently just under $4060, and silver is at $59. This represents a decline of 25% and 50%, respectively, relative to the local peaks reached just a few months ago.

πŸ“ˆ Macroeconomic Data Japan Retail sales for May exceeded expectations, accelerating to a level unseen since November 2023. Strengthening domestic consumption, in the face of persistent high price pressure and a weakening yen, could be a significant argument for further monetary policy tightening by the Bank of Japan. However, a rate hike before the end of the year is not yet fully priced in (approximately 87% market-implied probability

Register a Revolut Business Account
```

Market Analysis & Disclaimer

The market information, analysis, commentary, forecasts and opinions contained in this publication are provided by Octalas Group Ltd on behalf of Today Markets and Currency Hedger using information and data obtained from sources believed to be reliable. However, Octalas Group Ltd, Today Markets and Currency Hedger do not warrant or guarantee the accuracy, completeness or timeliness of the information presented and accept no responsibility for any loss or damage arising from reliance upon information contained herein, to the extent permitted by applicable law.

Market forecasts, expectations and opinions are based on analysis of available information and a number of assumptions regarding economic, financial, political and market conditions. Such assumptions may prove to be incorrect, and actual market developments may differ materially from those described or anticipated.

Nothing contained in this publication constitutes investment advice, financial advice, a personal recommendation, an offer, solicitation or invitation to buy, sell or otherwise transact in any financial instrument or investment product. The information is provided for general informational and educational purposes only and does not take into account the investment objectives, financial situation, experience or particular circumstances of any individual reader.

Past performance is not indicative of future results. Financial markets, including foreign exchange, commodities, equities, derivatives and other financial instruments, involve risk and prices can move rapidly. Readers should conduct their own independent research and, where appropriate, obtain advice from an appropriately authorised financial professional before making any investment or trading decision.

Where this publication refers to Today Markets, it represents market news, research, analysis and commentary published for informational purposes. Where Currency Hedger is referenced, it represents commentary concerning foreign exchange, currency exposure, international payments and hedging-related topics. References to particular financial instruments, markets, companies, currencies or commodities should not be interpreted as a recommendation to transact in them.

Octalas Group Ltd, Today Markets and Currency Hedger may have commercial interests or relationships with businesses, financial-service providers, technology providers or other market participants mentioned in their publications. Where relevant, such relationships or interests may create potential conflicts of interest. Appropriate measures are intended to be taken to ensure that published analysis and commentary are presented objectively and that commercial considerations do not determine the substance of market analysis.

The views expressed in this publication are those of the author or contributors at the time of publication and may change without notice as market conditions develop. Readers should not assume that any information contained herein has been updated following publication.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button